Table 3.

Relationship Between Intratumoral and Peritumoral ZBTB20 and Clinicopathologic Features

	Intratumoral ZBTB20			Peritumoral ZBTB20
Variable	High (n = 42, 41.2%)	Low (n = 60, 58.8%)	P	High (n = 42, 41.2%)	Low (n = 60, 58.8%)	P
Age(years)			0.523			1.0
≤50	19	31		20	30
>50	23	29		22	30
Gender			0.188			0.188
Male	36	45		36	45
Female	6	15		6	15
Tumor size(mm)			0.299			0.550
≤50	10	20		11	19
>50	32	40		31	41
AFP(ng/ml)
≤20	10	16	0.745	11	15	0.892
>20	32	44		31	45
HBsAg			0.302			0.106
Positive	38	50		39	49
Negtive	4	10		3	11
Pathological stage			0.396*			1.0*
I-II	1	5		2	4
III-IV	41	55		40	56
Liver cirrhosis			0.675			0.172
Yes	31	42		27	46
No	11	18		15	14
Tumor encapsulation			0.235			0.446
Complete	12	27		13	26
Uncomplete	10	10		9	11
No	20	23		20	23
Vein invasion			0.016			0.161
Present	13	7		11	9
Absent	29	53		31	51
Tumour multiplicity			0.064			0.589
Solitary	25	46		28	43
Multiple	17	14		14	17
TNM stage			0.07			0.573
I-II	22	5		25	39
III	20	55		17	21
Recurrence			0.003			0.001
Yes	37	37		38	36
No	5	23		4	24
Metastasis			0.000			0.08
Yes	27	16		22	21
No	15	44		20	39

Abbreviations: HBsAg, hepatitis B s antigen.

*Twenty-five percent of all the cells have expected count less than 5; Fisher's exact test.